Arkolith/Insider Trading/WST/Form 4

Poussot Rodolphe Jean

SVP, Strategy & Corporate DevWEST PHARMACEUTICAL SERVICES INC (WST) · full profile →Form 4 · filed Feb 19, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Tax withholding(F)28$248.26$7K307
Feb 18, 2026Option exercise(M)82——335

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 18, 2026Option exercise(M)82—$0248

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000105770-26-000020) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML